Clinical trial
A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to…
NCT00074620 · Speedel Pharma Ltd., Industry · Completed
Key facts
| NCT number | NCT00074620 |
|---|---|
| Title | A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis |
| Official title | A Randomised, Multicenter, Open-Label, Parallel Group Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Unfractionated Heparin as Anticoagulant Treatment in Patients Undergoing Haemodialysis Via an Arteriovenous Graft |
| Lead sponsor | Speedel Pharma Ltd., Industry |
| Collaborators | Quintiles, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Kidney Failure, Vascular Graft Occlusion |
| Intervention type | Drug |
| Interventions | PEG-hirudin |
| Enrollment | 260 |
| Start date | Nov 1, 2003 |
| Completion | Jan 1, 2006 |
| First posted | Dec 19, 2003 |
| Last update posted | Oct 5, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: